BIOMAT Database Logo BIOMAT Database Logo

Interferon for mixed cryoglobulinemia associated with hepatitis C. 1992

P Disdier, and J R Harlé, and P J Weiller

UI MeSH Term Description Entries
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

P Disdier, and J R Harlé, and P J Weiller
[Mixed cryoglobulinemia associated with hepatitis C virus. Value of interferon].
January 1992, Presse medicale (Paris, France : 1983),
P Disdier, and J R Harlé, and P J Weiller
Low-dose interferon-alpha for mixed cryoglobulinemia associated with hepatitis C virus.
October 1992, The American journal of medicine,
P Disdier, and J R Harlé, and P J Weiller
Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
February 1998, Journal of hepatology,
P Disdier, and J R Harlé, and P J Weiller
Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
July 1997, Journal of hepatology,
P Disdier, and J R Harlé, and P J Weiller
[Mixed cryoglobulinemia associated with hepatitis C virus].
January 1995, Revista espanola de enfermedades digestivas,
P Disdier, and J R Harlé, and P J Weiller
[Mixed cryoglobulinemia associated with hepatitis C infection].
October 1992, Medicina clinica,
P Disdier, and J R Harlé, and P J Weiller
[Mixed cryoglobulinemia and chronic hepatitis C. Treatment with interferon].
May 1993, Medicina clinica,
P Disdier, and J R Harlé, and P J Weiller
Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia.
May 1998, The New England journal of medicine,
P Disdier, and J R Harlé, and P J Weiller
[Mixed cryoglobulinemia associated with hepatitis C virus infection].
December 1991, Presse medicale (Paris, France : 1983),
P Disdier, and J R Harlé, and P J Weiller
Mixed cryoglobulinemia associated with hepatitis C virus infection.
May 2000, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!